|
|
Volumn 147, Issue 9, 2007, Pages 593-602
|
|
Risperidone for treatment-refractory major depressive disorder: A randomized trial
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
CITALOPRAM;
ESCITALOPRAM;
FLUOXETINE;
MIRTAZAPINE;
PAROXETINE;
PLACEBO;
RISPERIDONE;
SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRAZODONE;
VENLAFAXINE;
ZALEPLON;
ZOLPIDEM;
ANTIDEPRESSANT AGENT;
NEUROLEPTIC AGENT;
ADULT;
AKATHISIA;
ARTHRALGIA;
ARTICLE;
ATTENTION DISTURBANCE;
BRONCHITIS;
CHOLECYSTITIS;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEMOGRAPHY;
DEPRESSION;
DIARRHEA;
DIZZINESS;
DOUBLE BLIND PROCEDURE;
DRUG WITHDRAWAL;
DYSPEPSIA;
DYSTONIA;
FATIGUE;
FEMALE;
FEVER;
FOLLOW UP;
HAMILTON SCALE;
HEADACHE;
HUMAN;
INSOMNIA;
LETHARGY;
LOWER ABDOMINAL PAIN;
MAJOR CLINICAL STUDY;
MAJOR DEPRESSION;
MALAISE;
MALE;
MORBIDITY;
MORTALITY;
MULTICENTER STUDY;
NAUSEA;
PANCREATITIS;
PANIC;
PERIPHERAL EDEMA;
PREVALENCE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
RHINOPHARYNGITIS;
SIDE EFFECT;
SINUSITIS;
SOMNOLENCE;
STATISTICAL ANALYSIS;
TREMOR;
WEIGHT GAIN;
XEROSTOMIA;
ADOLESCENT;
AGED;
DRUG COMBINATION;
MIDDLE AGED;
PROSPECTIVE STUDY;
ADOLESCENT;
ADULT;
AGED;
ANTIDEPRESSIVE AGENTS;
ANTIPSYCHOTIC AGENTS;
DEPRESSIVE DISORDER, MAJOR;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
QUALITY OF LIFE;
REMISSION INDUCTION;
RISPERIDONE;
|
|
EID: 38449106889
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-147-9-200711060-00003 Document Type: Article |
|
Times cited : (136)
|
|
References (49)
|
